A detailed history of Kore Private Wealth LLC transactions in Immuneering Corp stock. As of the latest transaction made, Kore Private Wealth LLC holds 58,649 shares of IMRX stock, worth $131,960. This represents 0.15% of its overall portfolio holdings.

Number of Shares
58,649
Previous 59,024 0.64%
Holding current value
$131,960
Previous $319,000 163.32%
% of portfolio
0.15%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$5.0 - $14.32 $1,875 - $5,370
-375 Reduced 0.64%
58,649 $840,000
Q1 2022

May 13, 2022

BUY
$6.47 - $16.99 $264,778 - $695,298
40,924 Added 226.1%
59,024 $382,000
Q4 2021

Feb 11, 2022

BUY
$16.12 - $31.02 $64,480 - $124,080
4,000 Added 28.37%
18,100 $293,000
Q3 2021

Nov 15, 2021

BUY
$17.0 - $32.84 $239,700 - $463,044
14,100 New
14,100 $374,000

Others Institutions Holding IMRX

About Immuneering Corp


  • Ticker IMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,392,300
  • Market Cap $59.4M
  • Description
  • Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...
More about IMRX
Track This Portfolio

Track Kore Private Wealth LLC Portfolio

Follow Kore Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kore Private Wealth LLC with notifications on news.